Supported by the BioPharma Business Group, the Pharma Innovations Summit will gather key decision makers from the pharmaceutical, Biotech and Medical Devices industries to discuss the one issue of premier importance to all generating fresh revenue via extending product lifescycles, strategic partnerships and finding new ways to shrink the product-to-market timeline.
The Summit will challenge the audience to re-think existing business models and take a more Open approach that looks beyond early stage targets that often take 10-15 years to bring to market. This unique format helps to identify more applied, later stage partnering opportunities with shorter time-to-market potential. The identification and incubation of these new targets helps pharma executives take a more data-centric, reality-based look at converting scientific related business opportunities into revenue as they continue down the path of creating a more integrated healthcare community.
